Komori
COSMOS Pharmaceutical (3349) · FactDropped

Solid Same-Store Sales Performance

First written in FY2018-Q2. 2 of 5 entries say "Dropped", first in FY2019. Latest entry: FY2020.

5entries
3years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseOtherFY2018-Q2 – FY20202018: 220182019: 120192020: 22020
Same theme, other companies
Year-on-Year Trend in Same-Store SalesA theme 61 companies write about · 13 as a headwind · 46 as a tailwind

The whole theme swung hardest in 2020: 16 of 44 companies on the "Worse" side.

5 other companies' latest entry also says "Dropped".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 61 companies compared. The sentences above are computed from all 61.
Full recordFilings, disclosures and news, newest first
  1. FY2020DroppedAnnual report
    The current consolidated fiscal year’s discussion of operating results contains no explicit reference to the steady trend in same-store sales mentioned in the previous quarterly report.
  2. FY2020-Q2ReappearedAnnual report

    「However, sales remained steady, with same-store sales up 3.2% year on year in November.」

    The disclosure again reports same-store sales, for which no explicit reference had been identified in the previous fiscal year’s full-year discussion, showing a 3.2% year-on-year increase in November.
  3. FY2019DroppedAnnual report
    The current fiscal year’s discussion of operating results contains no explicit reference to the steady trend in same-store sales that had been mentioned through the previous fiscal year.
  4. FY2018-Q3Update: same-store sales trendAnnual report

    「Accordingly, the gross profit margin declined from the same period of the previous year, but same-store sales remained steady. In particular, the year-on-year monthly growth rate in same-store sales increased from December 2017 onward.」

    The company explains that the gross profit margin declined from the same period of the previous year, while same-store sales remained steady and the year-on-year monthly growth rate increased from December 2017 onward.
  5. FY2018-Q2First statedAnnual report

    「As a result, the gross margin declined from the previous year, but existing-store sales remained steady.」

    The company explains that the gross profit margin declined from the same period of the previous year as it strengthened its low-price policy and discount strategy, while same-store sales remained steady.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for COSMOS Pharmaceutical yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.